M Pharmaceutical Inc Stock Deutsche Boerse AG
Equities
CA55346E2050
Biotechnology & Medical Research
Sales 2018 | 0.75 0.7 | Sales 2019 | 0.71 0.66 | Capitalization | 3.53M 3.29M |
---|---|---|---|---|---|
Net income 2018 | -5M -4.67M | Net income 2019 | -1M -933K | EV / Sales 2018 | 4,852,616 x |
Net Debt 2018 | 319K 298K | Net Debt 2019 | 848K 791K | EV / Sales 2019 | 6,168,166 x |
P/E ratio 2018 |
-0.6
x | P/E ratio 2019 |
-1.97
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 72.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 18-01-02 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 14-11-30 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
1st Jan change | Capi. | |
---|---|---|
+1.46% | 42.75B | |
+47.70% | 41.61B | |
+12.30% | 41.34B | |
-8.83% | 26.59B | |
+6.78% | 25.49B | |
-23.14% | 18.12B | |
+30.20% | 12.24B | |
-2.41% | 11.76B | |
+8.46% | 11B |